{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T18:11:51Z","timestamp":1776363111733,"version":"3.51.2"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T00:00:00Z","timestamp":1624320000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cegh.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Epidemiology and Global Health"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.cegh.2021.100826","type":"journal-article","created":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T11:47:28Z","timestamp":1624967248000},"page":"100826","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"special_numbering":"C","title":["The antiviral activity of iota-, kappa-, and lambda-carrageenan against COVID-19: A critical review"],"prefix":"10.1016","volume":"12","author":[{"given":"Andri","family":"Frediansyah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cegh.2021.100826_bib1","doi-asserted-by":"crossref","first-page":"138882","DOI":"10.1016\/j.scitotenv.2020.138882","article-title":"COVID-19 outbreak: migration, effects on society, global environment and prevention","volume":"728","author":"Chakraborty","year":"2020","journal-title":"Sci Total Environ"},{"key":"10.1016\/j.cegh.2021.100826_bib2","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/emp2.12040","article-title":"Coronavirus disease 2019: international public health considerations","volume":"1","author":"Greene","year":"2020","journal-title":"Journal of the American College of Emergency Physicians Open"},{"key":"10.1016\/j.cegh.2021.100826_bib3","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1080\/21645515.2020.1830683","article-title":"SARS-CoV-2 reinfection and implications for vaccine development","volume":"16","author":"Nainu","year":"2020","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.cegh.2021.100826_bib4","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1001\/jama.2020.6266","article-title":"Rates of co-infection between SARS-CoV-2 and other respiratory pathogens","volume":"323","author":"Kim","year":"2020","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.cegh.2021.100826_bib5","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.cell.2020.05.042","article-title":"SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract","volume":"182","author":"Hou","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.cegh.2021.100826_bib6","doi-asserted-by":"crossref","first-page":"101623","DOI":"10.1016\/j.tmaid.2020.101623","article-title":"Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis","author":"Rodriguez-Morales","year":"2020","journal-title":"Trav Med Infect Dis"},{"key":"10.1016\/j.cegh.2021.100826_bib7","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1080\/17476348.2020.1778470","article-title":"Multiple organ dysfunction in SARS-CoV-2: MODS-CoV-2","volume":"14","author":"Robba","year":"2020","journal-title":"Expet Rev Respir Med"},{"key":"10.1016\/j.cegh.2021.100826_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-020-03062-7","article-title":"The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection","volume":"24","author":"Pons","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.cegh.2021.100826_bib9","first-page":"10","article-title":"Hemorrhagic and ischemic stroke in patients with coronavirus disease 2019: incidence, risk factors, and pathogenesis-a systematic review and meta-analysis","author":"Syahrul","year":"2021","journal-title":"F1000Research"},{"key":"10.1016\/j.cegh.2021.100826_bib10","first-page":"10","article-title":"Anosmia and dysgeusia in SARS-CoV-2 infection: incidence and effects on COVID-19 severity and mortality, and the possible pathobiology mechanisms-a systematic review and meta-analysis","author":"Mutiawati","year":"2021","journal-title":"F1000Research"},{"key":"10.1016\/j.cegh.2021.100826_bib11","doi-asserted-by":"crossref","first-page":"301","DOI":"10.12688\/f1000research.52216.1","article-title":"Global prevalence of prolonged gastrointestinal symptoms in COVID-19 survivors and potential pathogenesis: a systematic review and meta-analysis","volume":"10","author":"Yusuf","year":"2021","journal-title":"F1000Research"},{"key":"10.1016\/j.cegh.2021.100826_bib12","author":"Worldometers"},{"key":"10.1016\/j.cegh.2021.100826_bib13","article-title":"The reproductive number R0 of COVID-19 based on estimate of a statistical time delay dynamical system","author":"Shao","year":"2020","journal-title":"MedRxiv"},{"key":"10.1016\/j.cegh.2021.100826_bib14","series-title":"Antivirals for COVID-19: A Critical Review","volume":"9","author":"Frediansyah","year":"2020"},{"key":"10.1016\/j.cegh.2021.100826_bib15","first-page":"952","article-title":"SARS-CoV-2 variants and ending the COVID-19 pandemic","volume":"397","author":"Fontanet","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cegh.2021.100826_bib16","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.cegh.2021.100826_bib17","series-title":"Remdesivir and its Antiviral Activity against COVID-19: A Systematic Review","volume":"9","author":"Frediansyah","year":"2020"},{"key":"10.1016\/j.cegh.2021.100826_bib18","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3390\/scipharm88030036","article-title":"Antiviral activity of ivermectin against SARS-CoV-2: an old-fashioned dog with a new trick\u2014a literature review","volume":"88","author":"Mudatsir","year":"2020","journal-title":"Sci Pharm"},{"key":"10.1016\/j.cegh.2021.100826_bib19","first-page":"1","article-title":"Ivermectin as a potential drug for treatment of COVID-19: an in-sync review with clinical and computational attributes","author":"Kaur","year":"2021","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.cegh.2021.100826_bib20","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1001\/jama.2020.4940","article-title":"Convalescent plasma to treat COVID-19: possibilities and challenges","volume":"323","author":"Roback","year":"2020","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.cegh.2021.100826_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.630982","article-title":"Effect of convalescent plasma in critically ill patients with COVID-19: an observational study","volume":"8","author":"Kurtz","year":"2021","journal-title":"Front Med"},{"key":"10.1016\/j.cegh.2021.100826_bib22","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/s41565-020-0674-9","article-title":"Insights from nanomedicine into chloroquine efficacy against COVID-19","volume":"15","author":"Hu","year":"2020","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.cegh.2021.100826_bib23","doi-asserted-by":"crossref","first-page":"104760","DOI":"10.1016\/j.antiviral.2020.104760","article-title":"The broad spectrum antiviral ivermectin targets the host nuclear transport importin \u03b1\/\u03b21 heterodimer","volume":"177","author":"Yang","year":"2020","journal-title":"Antivir Res"},{"key":"10.1016\/j.cegh.2021.100826_bib24","doi-asserted-by":"crossref","first-page":"100719","DOI":"10.1016\/j.drup.2020.100719","article-title":"FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) therapy","author":"Dro\u017cd\u017cal","year":"2020","journal-title":"Drug Resist Updates"},{"key":"10.1016\/j.cegh.2021.100826_bib25","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.3390\/cells10051052","article-title":"Remdesivir and ledipasvir among the FDA-approved antiviral drugs have potential to inhibit SARS-CoV-2 replication","volume":"10","author":"Pirzada","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.cegh.2021.100826_bib26","unstructured":"WHO. \u201cSolidarity\u201d Clinical Trial for COVID-19 Treatments 2020."},{"key":"10.1016\/j.cegh.2021.100826_bib27","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1016\/S2213-2600(20)30530-0","article-title":"Corticosteroids for COVID-19: the search for an optimum duration of therapy","volume":"9","author":"Mishra","year":"2021","journal-title":"The Lancet. Respiratory Medicine"},{"key":"10.1016\/j.cegh.2021.100826_bib28","doi-asserted-by":"crossref","first-page":"116568","DOI":"10.1016\/j.carbpol.2020.116568","article-title":"Antitumor potential of carrageenans from marine red algae","author":"Khotimchenko","year":"2020","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.cegh.2021.100826_bib29","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3390\/jmse8070481","article-title":"Marine algae polysaccharides as basis for wound dressings, drug delivery, and tissue engineering: a review","volume":"8","author":"Kuznetsova","year":"2020","journal-title":"J Mar Sci Eng"},{"key":"10.1016\/j.cegh.2021.100826_bib30","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1128\/JCM.36.2.539-542.1998","article-title":"Viruses and bacteria in the etiology of the common cold","volume":"36","author":"M\u00e4kel\u00e4","year":"1998","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cegh.2021.100826_bib31","first-page":"1","article-title":"Lessons learned from a double-blind randomised placebo-controlled study with a iota-carrageenan nasal spray as medical device in children with acute symptoms of common cold","volume":"12","author":"Fazekas","year":"2012","journal-title":"BMC Compl Alternative Med"},{"key":"10.1016\/j.cegh.2021.100826_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1743-422X-5-107","article-title":"Iota-Carrageenan is a potent inhibitor of rhinovirus infection","volume":"5","author":"Grassauer","year":"2008","journal-title":"Virol J"},{"key":"10.1016\/j.cegh.2021.100826_bib33","series-title":"Carrageenan. Industrial Gums","first-page":"145","author":"Therkelsen","year":"1993"},{"key":"10.1016\/j.cegh.2021.100826_bib34","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1104\/pp.61.4.663","article-title":"Sulfohydrolase activity and carrageenan biosynthesis in Chondrus crispus (Rhodophyceae)","volume":"61","author":"Wong","year":"1978","journal-title":"Plant Physiol"},{"key":"10.1016\/j.cegh.2021.100826_bib35","doi-asserted-by":"crossref","first-page":"432","DOI":"10.3390\/md18090432","article-title":"Expression of genes related to carrageenan synthesis during carposporogenesis of the red seaweed grateloupia imbricata","volume":"18","author":"Garcia-Jimenez","year":"2020","journal-title":"Mar Drugs"},{"key":"10.1016\/j.cegh.2021.100826_bib36","first-page":"171","article-title":"Carrageenan from the tetrasporic stage of Gigartina decipiens (Gigartinaceae, rhodophyta)","volume":"252","author":"Falshaw","year":"1994","journal-title":"Carbohydr Res"},{"key":"10.1016\/j.cegh.2021.100826_bib37","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s10811-007-9270-8","article-title":"Carrageenan of eucheuma isiforme (Solieriaceae, rhodophyta) from Nicaragua","volume":"20","author":"Freile-Pelegr\u00edn","year":"2008","journal-title":"J Appl Phycol"},{"key":"10.1016\/j.cegh.2021.100826_bib38","series-title":"Carrageenans. Hydrocolloid Applications","first-page":"40","author":"Nussinovitch","year":"1997"},{"key":"10.1016\/j.cegh.2021.100826_bib39","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ijbiomac.2016.11.095","article-title":"A review on synthesis, properties and applications of natural polymer based carrageenan blends and composites","volume":"96","author":"Zia","year":"2017","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.cegh.2021.100826_bib40","first-page":"116","article-title":"Production, properties and uses of carrageenan. Production utilization of products from commercial seaweeds","volume":"288","author":"Stanley","year":"1987","journal-title":"FAO Fish Tech Pap"},{"key":"10.1016\/j.cegh.2021.100826_bib41","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.foodhyd.2013.01.019","article-title":"Kappa carrageenan fluid gel material properties. Part 2: Tribology","volume":"33","author":"Garrec","year":"2013","journal-title":"Food Hydrocolloids"},{"key":"10.1016\/j.cegh.2021.100826_bib42","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.2042-7158.1972.tb08940.x","article-title":"Biological properties of carrageenan","volume":"24","author":"Di Rosa","year":"1972","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.cegh.2021.100826_bib43","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3109\/10408444.2013.861798","article-title":"Food additive carrageenan: Part II: a critical review of carrageenan in vivo safety studies","volume":"44","author":"Weiner","year":"2014","journal-title":"Crit Rev Toxicol"},{"key":"10.1016\/j.cegh.2021.100826_bib44","first-page":"1","article-title":"Antitumor and adjuvant activity of \u03bb-carrageenan by stimulating immune response in cancer immunotherapy","volume":"5","author":"Luo","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.cegh.2021.100826_bib45","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.ijbiomac.2020.12.151","article-title":"Antitumor\/antiviral carbon quantum dots based on carrageenan and pullulan","volume":"170","author":"Emam","year":"2021","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.cegh.2021.100826_bib46","first-page":"1","article-title":"A sulfated polysaccharide \u03ba-carrageenan induced antioxidant defense and proteomic changes in chloroplast against leaf spot disease of tomato","author":"Mani","year":"2021","journal-title":"J Appl Phycol"},{"key":"10.1016\/j.cegh.2021.100826_bib47","doi-asserted-by":"crossref","first-page":"108234","DOI":"10.1016\/j.carres.2021.108234","article-title":"Semi-synthesis of N-alkyl-kappa-carrageenan derivatives and evaluation of their antibacterial activity","volume":"499","author":"J\u00fanior","year":"2021","journal-title":"Carbohydr Res"},{"key":"10.1016\/j.cegh.2021.100826_bib48","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0141-8130(96)01145-2","article-title":"Antiherpetic and anticoagulant properties of carrageenans from the red seaweed Gigartina skottsbergii and their cyclized derivatives: correlation between structure and biological activity","volume":"20","author":"Carlucci","year":"1997","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.cegh.2021.100826_bib49","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.carbpol.2012.08.034","article-title":"Selective sulfation of carrageenans and the influence of sulfate regiochemistry on anticoagulant properties","volume":"91","author":"de Ara\u00fajo","year":"2013","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.cegh.2021.100826_bib50","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.carbpol.2019.03.057","article-title":"Effects of carboxyl group on the anticoagulant activity of oxidized carrageenans","volume":"214","author":"dos Santos-Fidencio","year":"2019","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.cegh.2021.100826_bib51","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.canlet.2005.11.032","article-title":"Immunomodulation and antitumor activity of \u03ba-carrageenan oligosaccharides","volume":"243","author":"Yuan","year":"2006","journal-title":"Canc Lett"},{"key":"10.1016\/j.cegh.2021.100826_bib52","first-page":"1","article-title":"Immunomodulating properties of carrageenan from tichocarpus crinitus","author":"Cicinskas","year":"2020","journal-title":"Inflammation"},{"key":"10.1016\/j.cegh.2021.100826_bib53","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1128\/AAC.31.9.1388","article-title":"Polysaccharides as antiviral agents: antiviral activity of carrageenan","volume":"31","author":"Gonzalez","year":"1987","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cegh.2021.100826_bib54","first-page":"1","article-title":"Antiviral activity of lambda-carrageenan against influenza viruses and severe acute respiratory syndrome coronavirus 2","volume":"11","author":"Jang","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.cegh.2021.100826_bib55","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3390\/md18110583","article-title":"Drug delivery systems and other biomedical applications","volume":"18","author":"Pacheco-Quito","year":"2020","journal-title":"Mar Drugs"},{"key":"10.1016\/j.cegh.2021.100826_bib56","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1128\/AAC.32.11.1742","article-title":"Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, and human immunodeficiency virus","volume":"32","author":"Baba","year":"1988","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cegh.2021.100826_bib57","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0166-3542(90)90009-V","article-title":"Inhibitory effect of selected antiviral compounds on arenavirus replication in vitro","volume":"14","author":"Andrei","year":"1990","journal-title":"Antivir Res"},{"key":"10.1016\/j.cegh.2021.100826_bib58","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0166-3542(91)90031-L","article-title":"Antiviral activity of sulfated polysaccharides against African swine fever virus","volume":"15","author":"Garc\u00eda-Villal\u00f3n","year":"1991","journal-title":"Antivir Res"},{"key":"10.1016\/j.cegh.2021.100826_bib59","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0166-3542(88)90035-6","article-title":"Pentosan polysulfate, a sulfated oligosaccharide, is a potent and selective anti-HIV agent in vitro","volume":"9","author":"Baba","year":"1988","journal-title":"Antivir Res"},{"key":"10.1016\/j.cegh.2021.100826_bib60","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3851\/IMP3295","article-title":"Inhibitory effect of iota-carrageenan on porcine reproductive and respiratory syndrome virus in vitro","volume":"24","author":"Guo","year":"2019","journal-title":"Antivir Ther"},{"key":"10.1016\/j.cegh.2021.100826_bib61","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.virol.2007.01.043","article-title":"Interference in dengue virus adsorption and uncoating by carrageenans","volume":"363","author":"Talarico","year":"2007","journal-title":"Virol J"},{"key":"10.1016\/j.cegh.2021.100826_bib62","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0166-3542(89)90033-8","article-title":"Anti-HIV activity of dextran sulphate as determined under different experimental conditions","volume":"11","author":"Nakashima","year":"1989","journal-title":"Antivir Res"},{"key":"10.1016\/j.cegh.2021.100826_bib63","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/0006-2952(90)90161-D","article-title":"Inhibition of HIV-1 infectivity with curdlan sulfate in vitro","volume":"39","author":"Yutaro","year":"1990","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.cegh.2021.100826_bib64","first-page":"646","article-title":"Dextran sulfate suppression of viruses in the HIV family: inhibition of virion binding to CD4+ cells","volume":"240","author":"Mitsuya","year":"1988","journal-title":"Sci Total Environ"},{"key":"10.1016\/j.cegh.2021.100826_bib65","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1007\/BF01953060","article-title":"Further characterization of sulfated homopolysaccharides as anti-HIV agents","volume":"45","author":"Sugawara","year":"1989","journal-title":"Experientia"},{"key":"10.1016\/j.cegh.2021.100826_bib66","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1089\/aid.1992.8.19","article-title":"Investigations into the mechanism by which sulfated polysaccharides inhibit HIV infection in vitro","volume":"8","author":"McClure","year":"1992","journal-title":"AIDS Res Hum Retrovir"},{"key":"10.1016\/j.cegh.2021.100826_bib67","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1159\/000007236","article-title":"Inhibitory action of natural carrageenans on Herpes simplex virus infection of mouse astrocytes","volume":"45","author":"Carlucci","year":"1999","journal-title":"Chemotherapy"},{"key":"10.1016\/j.cegh.2021.100826_bib68","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.antiviral.2012.05.009","article-title":"Prevention of human enterovirus 71 infection by kappa carrageenan","volume":"95","author":"Chiu","year":"2012","journal-title":"Antivir Res"},{"key":"10.1016\/j.cegh.2021.100826_bib69","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.antiviral.2011.08.010","article-title":"In vitro inhibitory effect of carrageenan oligosaccharide on influenza A H1N1 virus","volume":"92","author":"Wang","year":"2011","journal-title":"Antivir Res"},{"key":"10.1016\/j.cegh.2021.100826_bib70","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014320","article-title":"Iota-carrageenan is a potent inhibitor of influenza A virus infection","volume":"5","author":"Leibbrandt","year":"2010","journal-title":"PloS One"},{"key":"10.1016\/j.cegh.2021.100826_bib71","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128794","article-title":"The intranasal application of Zanamivir and carrageenan is synergistically active against influenza A virus in the murine model","volume":"10","author":"Morokutti-Kurz","year":"2015","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.cegh.2021.100826_bib72","first-page":"74","article-title":"Bio-function summary of marine oligosaccharides","volume":"3","author":"Ji","year":"2011","journal-title":"Int J Biol"},{"key":"10.1016\/j.cegh.2021.100826_bib73","first-page":"2193","article-title":"Synthesis of \u03b2-(1\u2192 6)-branched \u03b2-(1\u2192 3) glucohexaose and its analogues containing an \u03b1-(1\u2192 3) linked bond with antitumor activity","volume":"11","author":"Ning","year":"2003"},{"key":"10.1016\/j.cegh.2021.100826_bib74","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1073\/pnas.57.4.933","article-title":"Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease","volume":"57","author":"McIntosh","year":"1967","journal-title":"PNAS"},{"issue":"2","key":"10.1016\/j.cegh.2021.100826_bib75","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0237480","article-title":"Iota-carrageenan neutralizes SARS-CoV-2 and inhibits viral replication in vitro","volume":"16","author":"Morokutti-Kurz","year":"2021","journal-title":"PloS One"},{"issue":"9","key":"10.1016\/j.cegh.2021.100826_bib76","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.1039\/D0FO02017F","article-title":"Inhibitory activities of marine sulfated polysaccharides against SARS-CoV-2","volume":"11","author":"Song","year":"2020","journal-title":"Food Funct"},{"issue":"12","key":"10.1016\/j.cegh.2021.100826_bib77","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.3390\/microorganisms8121894","article-title":"Sars-cov-2 inhibition by sulfonated compounds","volume":"8","author":"Gasbarri","year":"2020","journal-title":"Microorganisms"},{"issue":"5","key":"10.1016\/j.cegh.2021.100826_bib78","doi-asserted-by":"crossref","first-page":"L750","DOI":"10.1152\/ajplung.00552.2020","article-title":"Carrageenan containing over-the-counter nasal and oral sprays inhibit SARS-CoV-2 infection of airway epithelial cultures","volume":"320","author":"Sch\u00fctz","year":"2021","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.cegh.2021.100826_bib79","series-title":"Iota-carrageenan and xylitol inhibit SARS-CoV-2 in cell culture","author":"Bansal","year":"2020"},{"key":"10.1016\/j.cegh.2021.100826_bib80","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1177\/095632029300400607","article-title":"Protective effect of carrageenan against murine cytomegalovirus infection in mice","volume":"4","author":"Hamasuna","year":"1993","journal-title":"Antiviral Chem Chemother"},{"key":"10.1016\/j.cegh.2021.100826_bib81","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0166-3542(99)00020-0","article-title":"Plant products as topical microbicide candidates: assessment of in vitro and in vivo activity against herpes simplex virus type 2","volume":"42","author":"Bourne","year":"1999","journal-title":"Antivir Res"},{"key":"10.1016\/j.cegh.2021.100826_bib82","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.antiviral.2004.07.001","article-title":"Protective effect of a natural carrageenan on genital herpes simplex virus infection in mice","volume":"64","author":"Carlucci","year":"2004","journal-title":"Antivir Res"},{"key":"10.1016\/j.cegh.2021.100826_bib83","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nm1598","article-title":"Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan","volume":"13","author":"Roberts","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.cegh.2021.100826_bib84","first-page":"1","article-title":"Cyanobacterial Metabolites as Promising Drug Leads against the Mpro and PLpro of SARS-CoV-2: An in Silico Analysis","volume":"18","author":"Naidoo","year":"2020","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.cegh.2021.100826_bib85","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S1473-3099(05)70270-X","article-title":"Understanding the symptoms of the common cold and influenza","volume":"5","author":"Eccles","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cegh.2021.100826_bib86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1465-9921-11-108","article-title":"Efficacy and safety of an antiviral Iota-Carrageenan nasal spray: a randomized, double-blind, placebo-controlled exploratory study in volunteers with early symptoms of the common cold","volume":"11","author":"Eccles","year":"2010","journal-title":"Respir Res"},{"key":"10.1016\/j.cegh.2021.100826_bib87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1465-9921-14-124","article-title":"Efficacy of a carrageenan nasal spray in patients with common cold: a randomized controlled trial","volume":"14","author":"Ludwig","year":"2013","journal-title":"Respir Res"},{"key":"10.1016\/j.cegh.2021.100826_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12931-015-0281-8","article-title":"Efficacy and safety of iota-carrageenan nasal spray versus placebo in early treatment of the common cold in adults: the ICICC trial","volume":"16","author":"Eccles","year":"2015","journal-title":"Respir Res"},{"key":"10.1016\/j.cegh.2021.100826_bib89","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1021\/acschemneuro.0c00373","article-title":"Considerations around the SARS-CoV-2 Spike Protein with particular attention to COVID-19 brain infection and neurological symptoms","volume":"11","author":"Hassanzadeh","year":"2020","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.cegh.2021.100826_bib90","article-title":"Effectiveness of ivermectin as add-on therapy in COVID-19 management (pilot trial)","author":"Gorial","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.cegh.2021.100826_bib91","first-page":"15","article-title":"Use of ivermectin as a potential chemoprophylaxis for COVID-19 in Egypt: a randomized clinical trial","author":"Shoumann","year":"2021","journal-title":"J Clin Diagn Res"},{"key":"10.1016\/j.cegh.2021.100826_bib92","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.jconrel.2020.10.009","article-title":"Ivermectin: an award-winning drug with expected antiviral activity against COVID-19","volume":"329","author":"Formiga","year":"2021","journal-title":"J Contr Release"},{"key":"10.1016\/j.cegh.2021.100826_bib93","doi-asserted-by":"crossref","DOI":"10.31546\/2633-8653.1007","article-title":"Study of the efficacy and safety of topical ivermectin+ iota-carrageenan in the prophylaxis against COVID-19 in health personnel","volume":"2","author":"H\u00e9ctor","year":"2020","journal-title":"Journal of Biomedical Research and Clinical Investigation"},{"key":"10.1016\/j.cegh.2021.100826_bib94","article-title":"A randomized trial-intensive treatment based in ivermectin and iota-carrageenan as pre-exposure prophylaxis for COVID-19 in healthcare agents","author":"Chahla","year":"2021","journal-title":"medRxiv"},{"key":"10.1016\/j.cegh.2021.100826_bib95","first-page":"304","article-title":"Sulfation of kappa-carrageenan and antiviral activity","volume":"86","author":"Kolender","year":"1998","journal-title":"Anales-Asociation Quimica Argentina"},{"key":"10.1016\/j.cegh.2021.100826_bib96","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1371\/journal.ppat.0020069","article-title":"Carrageenan is a potent inhibitor of papillomavirus infection","volume":"2","author":"Buck","year":"2006","journal-title":"PLoS pathogen"},{"key":"10.1016\/j.cegh.2021.100826_bib97","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0140586","article-title":"\u03bb-carrageenan P32 is a potent inhibitor of rabies virus infection","volume":"10","author":"Luo","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.cegh.2021.100826_bib98","article-title":"Specific inhibitory effect of \u03ba-carrageenan polysaccharide on swine pandemic 2009 H1N1 influenza virus","volume":"10","author":"Shao","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.cegh.2021.100826_bib99","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1099\/vir.0.028522-0","article-title":"Differential inhibition of dengue virus infection in mammalian and mosquito cells by iota-carrageenan","volume":"92","author":"Talarico","year":"2011","journal-title":"J Gen Virol"},{"key":"10.1016\/j.cegh.2021.100826_bib100","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.rvsc.2014.11.010","article-title":"Antiviral activity of lambda-carrageenan prepared from red seaweed (Gigartina skottsbergii) against BoHV-1 and SuHV-1","volume":"98","author":"Diogo","year":"2015","journal-title":"Res Vet Sci"}],"container-title":["Clinical Epidemiology and Global Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213398421001342?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213398421001342?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T08:52:51Z","timestamp":1761987171000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213398421001342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":100,"alternative-id":["S2213398421001342"],"URL":"https:\/\/doi.org\/10.1016\/j.cegh.2021.100826","relation":{},"ISSN":["2213-3984"],"issn-type":[{"value":"2213-3984","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The antiviral activity of iota-, kappa-, and lambda-carrageenan against COVID-19: A critical review","name":"articletitle","label":"Article Title"},{"value":"Clinical Epidemiology and Global Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cegh.2021.100826","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author. Published by Elsevier B.V. on behalf of INDIACLEN.","name":"copyright","label":"Copyright"}],"article-number":"100826"}}